Influencers have been enthusiastically claiming its success in helping them lose weight, with their posts viewed by millions. You might be surprised what the evidence shows.
Academic rigour, journalistic flair
Articles on Diabetes
Displaying 1 - 20 of 355 articles
In a controversial move in 2021, drug-funding agency Pharmac fully subsidised new diabetes drugs for Māori and Pacific patients. Could the result help set a precedent?
Ozempic uses semaglutide to mimic the role of a hormone naturally produced by the body to create feelings of fullness. Certain foods can do the same thing.
Nine in ten of all deaths in New Zealand are caused by non-communicable diseases such as heart disease and diabetes. Better use of research evidence could save lives and healthcare dollars.
The drugmaker’s move responded to the growing competition that has shaken up the insulin market in recent years.
For parents, encouraging healthy family diets for children from the time they are babies is one way to keep children’s blood sugar levels in check. The Indonesian government can do more to help too.
As tempting as it is, it is not possible to “supplement” oneself out of a bad lifestyle.
Scientists are figuring out why so many diseases and conditions, including diabetes, inflammation and parasitic infection, can affect our eye health. But there are ways to protect your macula.
You’ve probably heard of the drug semaglutide or Ozempic, the diabetes medication being used for weight loss. So what are the risks and benefits? And who should have access to it?
The risk of developing eye complications is high in young people with Type 2 diabetes, which is increasingly affecting children and adolescents, especially those who are more sedentary.
Shift work throws our circadian rhythm out of whack, which can impact the major systems in our bodies.
On the centenary of insulin’s first use, doctors, researchers and people with diabetes are asking why New Zealand lags other countries in funding the latest devices to monitor blood sugar.
In Canada, 14.4 per cent of South Asians have Type 2 diabetes, the highest prevalence of any other ethnic group in the country. Why is this population so disproportionately affected by diabetes?
Improving diabetes care in South Africa requires strong will and support from health authorities, introduction of clinical information systems, the use of technology and digital solutions.
Large new study identifies very early risk factors for pancreatic cancer.
Outpatient visits, screening and diagnostic services, and child immunisation were particularly negatively affected.
It’s important to think about the weight-related outcomes are you’re hoping for and what other approaches could be tried first.
Most people with diabetes are poorly controlled. This makes them vulnerable to complications like eye problems, kidney disease, and even amputations.
Older people with COVID are at higher risk of a new Alzheimer’s diagnosis within a year of testing positive. Vaccination against viral infection remains one of several important preventative measures.
Lowering obesity and overweight rates will lift the burden on healthcare spending.
Job Board
-
Senior Lecturer in Endodontics
-
Project Manager, Research Domain
-
Sydney Horizon Fellowships (Climate Change, Health and Sustainability)
-
Dean, School of Engineering, Design and Built Environment
-
Head of School, Humanities
Top contributors
-
Professor of Medicine, Monash University
-
Professor (Hon) at Monash University, Baker Heart and Diabetes Institute
-
Professor of Public Health Policy, Deakin University
-
General Manager Diabetes Services, Baker Heart and Diabetes Institute
-
Laureate Professor in Nutrition and Dietetics, University of Newcastle
-
Professor and Programme Director, SA MRC Centre for Health Economics and Decision Science - PRICELESS SA (Priority Cost Effective Lessons in Systems Strengthening South Africa), University of the Witwatersrand
-
Associate Professor and Director of Evidence-Based Healthcare DPhil Programme, University of Oxford
-
Assistant Professor, Bond University
-
Professor of Physical Activity, Lifestyle, and Population Health, University of Sydney
-
Clinical Endocrinologist & Associate Lecturer, University of the Witwatersrand
-
Professor of Health Sciences, Simon Fraser University
-
Professor of Global Health, Institute for Applied Research, University of Birmingham
-
Senior researcher, University of the Witwatersrand
-
Project Manager, University of Pretoria Diabetes Research Centre, University of Pretoria
-
Professor and Laboratory Head of Physical Activity, Baker Heart and Diabetes Institute
